Imatinib reduces proliferation of leukemic cells in vitro
Introduction: Philadelphia chromosome is a cytogenetic marker for chronic myeloid leukemia (CML). The main aims of this study were to assess the positive responses, side-effects and survival of CML patients treated with imatinib mesylate.Methods: All recently diagnosed CML patients who were treated...
Gespeichert in:
Veröffentlicht in: | Bangladesh journal of medical science (Ibn Sina Trust) 2017, Vol.16 (2), p.320-324 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!